9.B.23. The TMEM106 (TMEM106) Family
TMEM106B variants are genetically associated with frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), and are considered a major risk factor for this disease. TMEM106B may also be involved in other pathologies such as Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). Schwenk et al. 2014 combined loss-of-function experiments, live imaging and proteomics to unveil the physiological roles played by TMEM106B and its binding partner MAP6 in lysosomal function and transport. Neuronal TMEM106B plays a central role in regulating lysosomal size, motility and responsiveness to stress (Stagi et al. 2014). Single-nucleotide polymorphisms: rs5848 (GRN), rs1990622 (TMEM106B), and rs704180 (ABCC9) are associated with hippocampal sclerosis of aging (HS-Aging), a common high-morbidity neurodegenerative condition in elderly persons (Nelson et al. 2015). The up-regulation of TMEM106B may increase the risk of FTLD by directly causing neurotoxicity and a pathological phenotype linked to FTLD-TDP (Suzuki and Matsuoka 2016). Nicholson and Rademakers 2016 summarized what was known about TMEM106B in 2016, including its role as a potential regulator of lysosomal function.
TMEM106C is overexpressed in hepatocellular carcinoma (HCC) cells, and inhibition of TMEM106C suppressed the proliferation and metastasis of HCC (Duan et al. 2021). Upregulation of TMEM106C correlated with sex, tumor stage, tumor grade and prognosis. Overexpression of TMEM106C was linked to functional networks involving organelle fission and cell cycle signaling pathways through the regulation of CDK kinases, E2F1 transcription factors and miRNAs. Thus, TMEM106C contributes to malignant characteristics and poor prognosis in HCC (Duan et al. 2021).
TMEM106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis (Xu et al. 2014). It activates mouse peritoneal macrophages via the MAPK and NF-κB signaling pathways (Dai et al. 2015). It is a tumor suppressor in human renal cancer, and may play a role in prostate, breast and ovarian cancers (Wu et al. 2017; Babalyan et al. 2016; Du et al. 2018). It inhibits cell proliferation and migration and induces apoptosis of lung cancer cells (Liu and Zhu 2018; Rizza et al. 2019). Moreover, inactivation of TMEM106A promotes lipopolysaccharide-induced inflammation via the MAPK and NF-kappaB signaling pathways in macrophages (Zhang et al. 2021).
Since the initial identification of TMEM106B as a risk factor for frontotemporal lobar degeneration (FTLD), multiple genetic studies have found TMEM106B variants to modulate disease risk in a variety of brain disorders and healthy aging (Perneel and Rademakers 2022). Neurodegenerative disorders are typically characterized by inclusions of misfolded proteins, and since lysosomes are an important site for cellular debris clearance, lysosomal dysfunction has been linked to neurodegeneration. Consequently, many causal mutations or genetic risk variants implicated in neurodegenerative diseases encode proteins involved in endosomal-lysosomal function. As an integral lysosomal transmembrane protein, TMEM106B regulates several aspects of lysosomal function, and multiple studies have shown that proper TMEM106B protein levels are crucial for maintaining lysosomal health. Perneel and Rademakers 2022 reviewed TMEM106B research. When TMEM106B is compromised, protein and lipid clearance by the lysosome is delayed. As TMEM106B contains putative lipid- and LC3-binding sites, this may be its primary function (Shafit-Zagardo et al. 2023).
The structure and functions of NDR1/HIN1-like (NHL) proteins in plant development and response to environmental stresses have been reported (Amato et al. 2025). The NON-RACE-SPECIFIC DISEASE RESISTANCE 1/harpin-induced 1-LIKE (NHL) gene family plays pivotal roles, including pathogen resistance, abiotic stress tolerance, and developmental regulation, underscoring their functional versatility in developmental and physiological processes of plants. NHL proteins often localize to the plasma membrane and contain conserved motifs, including the LEA2 and transmembrane domains, enabling dynamic interactions with signalling molecules and transcription factors. The ability of NHL proteins to dimerize and oligomerize further enhances their regulatory potential in signalling pathways. The review by Amato et al. 2025 explores the structural and functional diversity of NHL proteins including their localizations, interacting proteins, and responses to abiotic and biotic stresses, ion transport, seed germination, and responses to phytohormones. Future research integrating phylogenetics, and advanced tools including artificial intelligence will unlock the full potential of this gene family for breeding climate-resilient crops and agricultural sustainability.
References:
TMEM106B (transmembrane protein 106B) plays an integral role in microglia and oligodendrocyte function (Lok and Kwok 2021). It is of 274 aas with 1 or 2 TMSs. It is involved in several diseases and is linked to cell death (see family description) (Nicholson and Rademakers 2016). It exerts its effects on FTLD-TDP disease risk through alterations in lysosomal pathways, and TMEM106B and C9orf72 may interact in FTLD-TDP pathophysiology (Busch et al. 2016). Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation (Bauer et al. 2022). The TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia (Marks et al. 2024).
TMEM106B of Homo sapiens
Putative serine endopeptidase (DUF1356) of 466 aas and 2 - 5 TMSs.
Putative endopeptidase of Chlorella variabilis (Green alga)
Uncharacterized protein of 248 aas and 1 TMS.
UP of Chlamydomonas reinhardtii (Chlamydomonas smithii)
TMEM106C of 250 aas and 2 TMSs. TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma (HCC) (Duan et al. 2021). TMEM106C is overexpressed in HCC, and its inhibition suppresses the proliferation and metastasis of HCC. Upregulation of TMEM106C correlated with sex, tumor stage, tumor grade and prognosis. Overexpression of TMEM106C was linked to functional networks involving organelle fission and cell cycle signaling pathways (Duan et al. 2021).
TMEM23C of Homo sapiens
TMEM106A of 262 aas and 2 separated but fairly central TMSs. See paragraph 3 in the family description for details of studies and references.
TMEM106A of Homo sapiens
TMEM106A of 245 aas and 1 central TMS.
TMEM106A of Echinococcus granulosus
Late embryogenesis abundant (LEA) hydroxyproline-rich glycoprotein family isoform 1 of 250 aas and 1 TMS.
LEA protein of Morus notabilis
Uncharacterized protein of 226 aas and 1 TMS
UP of Prunus persica (Peach) (Amygdalus persica)
Uncharacterized protein of 221 aas and 1 TMS.
UP of Ricinus communis (Castor bean)
Uncharacterized protein of 256 aas and 1 TMS.
UP OF Populus trichocarpa (Western balsam poplar) (Populus balsamifera subsp. trichocarpa)
Uncharacterized protein of 641 aas and 1 TMS. The C-terminal domain (residues 180 - end) is homologous to TMEM106 proteins while the N-terminus (residues 181 - 170 is proline-rich and is homologous to members of the late embryogenesis abundant (LEA) hydroxyproline-rich glycoprotein family.
UP of Setaria italica (Foxtail millet) (Panicum italicum)
NDR1/HIN1-like (NHL) protein of 238 aas with 1 huge TMS.
NHL protein of Drosera capensis
Ndr1/hin1-like (NHL) protein of 454 aas and 1 huge TMS.
NHL of Anaeramoeba ignava
NDR1/HIN1-like (NHL) protein of 210 aas and 1 huge TMS.
NHL protein of Vitis vinifera
NDR1/HIN1-like (NHL) protein of 246 aas with 1 huge TMS.
NHL of Vigna angularis